Delivery Order 36C24E20D0028-36C24E22N0188
- Not listed
- The U.S. Department of Veterans Affairs has awarded a $6.3 million firm fixed-price delivery order to Infinity Biologix LLC for genomic analysis services. The award, issued on September 30, 2025, with an ultimate completion date of March 29, 2026, does not include a socioeconomic set-aside. Work will be performed in Washington, DC. Infinity Biologix LLC, a for-profit limited liability company based in Piscataway, New Jersey, operating through its Sampled Division, specializes in advanced...
- The U.S. Department of Veterans Affairs awarded a $4.4 million firm fixed-price delivery order to Infinity Biologix LLC for genomic analysis services, effective September 30, 2024, with completion targeted for September 29, 2025. Infinity Biologix, based in Piscataway, New Jersey, and operating through its Sampled Division, is a specialized biomedical research firm providing comprehensive genomic sequencing, DNA extraction, genotyping, and biorepository solutions to multiple federal agencies....
- The Department of Veterans Affairs, Veterans Integrated Service Network 1 (VISN 1), awarded a delivery order to Infinity Biologix LLC for long read sequencing services with a ceiling value of $1.19M. The contract employs firm fixed-price pricing with an ultimate completion date of March 1, 2027, and work will be performed in Piscataway, New Jersey. This delivery order was issued without a set-aside designation and represents task ordering under an existing vehicle established with the VA....
- The U.S. government awarded a $6.3 million firm fixed-price delivery order for genomic analysis services to Infinity Biologix LLC (doing business as Sampled Division), a biomedical research company based in Piscataway, New Jersey. The contract, awarded on September 30, 2023, with an ultimate completion date of September 29, 2025, will be performed in Washington, DC and funded by a civilian federal agency. This delivery order represents no set-aside designation and is part of the company's...
- Infinity Biologix LLC, operating as the Sampled Division and based in Piscataway, New Jersey, was awarded a delivery order valued at $13.5 million for genomic analysis services. The contract, issued on September 30, 2021, with an ultimate completion date of September 29, 2022, carries firm fixed-price terms and was funded by a civilian federal agency headquartered in Washington, DC. No socioeconomic set-aside was applied to this award. The delivery order represents a continuation of Infinity...
- Infinity Biologix LLC, operating through its Sampled Division and based in Piscataway, New Jersey, was awarded a delivery order for genomic analysis services valued at $1.6M under a firm fixed-price contract. The work will be performed in Boston, Massachusetts, with a completion target of September 29, 2025. This contract was awarded without a socioeconomic set-aside and represents a continuation of the company's established track record providing high-complexity genomic research services to...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Aging to Infinity Biologix LLC, a biorepository and laboratory services company, for DNA extraction and genotyping services. The contract is a firm fixed-price purchase order valued at $182,183.00, with a completion date of September 21, 2022. The contract does not have a set-aside designation. Infinity Biologix, through its Sampled division, has provided...
- This is a delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Infinity Biologix LLC, doing business as Sampled Division. The $2,712,502.66 firm-fixed-price contract is for the NIDA Center for Genetic Studies, covering the period from March 14, 2025 to March 13, 2026. The contract does not have a set-aside designation. Infinity Biologix is a leading provider of genomic analysis, sequencing, DNA extraction, genotyping, and biorepository services to...
- The Department of Veterans Affairs Veterans Integrated Service Network 4 awarded a $7.5 million firm fixed-price delivery order to Personalis, Inc. for whole genome sequencing services. The contract, which commenced on September 30, 2024, with an ultimate completion date of November 5, 2025, represents a continuation of the VA's genomic medicine initiatives supporting precision healthcare and medical research. This delivery order is issued under Personalis's existing $175 million indefinite...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of genetic and genomic analysis products and services. The $302,562.10 firm fixed price purchase order is for the supply of the INFINIUM MULTI-ETHNIC GLOBAL-8 V1.0 KIT (48 SAMPLES) to support the VA's genomic sequencing and analysis needs. This award is not associated with a set-aside. Illumina has previously received prime contract and subcontract awards from various federal...
- 36C24E20D0028Indefinite Delivery Contract
- 36C24E20D0028-36C24E22N0188Delivery Order
The Department of Veterans Affairs awarded a $12.5 million firm fixed-price delivery order for genomic analysis services to Infinity Biologix LLC (doing business as Sampled Division) on September 30, 2022, with completion scheduled for September 29, 2023. The contract, which received no socioeconomic set-aside, supports advanced biomedical research initiatives through the VA's civilian operations at its Washington, DC headquarters. Infinity Biologix, a Piscataway, New Jersey–based limited liability company specializing in high-complexity laboratory and genomic research services, will deliver comprehensive genomic analysis, DNA sequencing, genotyping, and related biorepository solutions under this delivery order. This award reflects Infinity Biologix's established position as a critical federal research service provider with a track record of supporting major health and science agencies including the National Institutes of Health, Centers for Disease Control and Prevention, National Institute on Drug Abuse, and Department of Agriculture. The company holds significant indefinite delivery contracts with federal agencies, including a $149.2 million genome characterization center services contract with the National Cancer Institute and a $15 million contract with the National Institute on Drug Abuse. The VA delivery order leverages the contractor's demonstrated expertise in next-generation sequencing, sample processing, and large-scale genomic characterization to support the department's research and clinical initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($252) | 3/15/26 | |
| Not listed | Not listed | $12.5m | 9/6/22 |